Also, Director Menelas N. Pangalos bought 95,785 shares of Absci stock in a transaction on Monday, September 22nd. BNP Paribas Financial Markets purchased a new position in shares of Absci in the fourth quarter valued at $28,000. Banque Transatlantique SA bought a new stake in shares of Absci during the 1st quarter valued at $28,000. Finally, AssuredPartners Investment Advisors LLC bought a new stake in shares of Absci during the 1st quarter valued at $29,000. Absci Company Profile(Get Free Report)Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.